Question Bank › Constraint-side candor

Constraint-side candor

Constraint-side candor: management freely details what it cannot yet do while demand is not the question

Calls Tested
500
Answered YES
31
Hit Rate
6.2%
rare by design

Accuray Incorporated (ARAY) — this company's answers

NO on the Q4 2016 call 2016-08-17 B
The model's full reasoning — Q4 2016 call → NO我们根据提供的财报电话会议记录来判断。管理层是否自愿且具体地详细说明了公司自身的当前限制（无法生产、服务、配备人员、交付或处理的内容），同时明确表明对其所售产品的需求不是问题，并将这种坦诚与已经进行的实际补救措施相结合？需要三个条件同时满足：具体自我识别的限制、需求被视为存在且已确定、修复措施正在进行中。 在记录中，管理层讨论了Radixact平台的新推出，提到他们正在安装和监控多个初始参考站点，并计划在2017财年下半年全面商业发布。他们表示：“我们正在安装和监控Radixact系统在多个初始参考站点……这些安装应在2017财年第一季度和第二季度初进行……我们将密切监控这些系统的性能……我们将通过2017财年下半年全面商业发布。”这暗示了系统尚未完全准备好，存在限制。但这是否是“具体自我识别的限制”？他们提到了新平台、新子系统，需要监控性能，但并未明确说“我们无法生产”或“无法交付”。他们提到“全面商业发布”将在下半年，这意味着目前无法全面供应。这算是一种限制。 关于需求，他们提到订单强劲，第四季度创纪录，但未明确说需求超过供应。他们提到Radixact的推出是第二半年的影响，但并未说需求被限制。 关于修复措施，他们正在安装参考站点，监控性能，这是正在进行的工作。 但整体上，管理层是否“自愿且具体地详细说明了公司自身的当前限制”？他们更多是在描述产品发布的时间表，而不是在列举无法满足的需求。他们提到“我们正在安装和监控……将移动至全面商业发布”，这更像是一个计划，而不是承认当前无法满足需求。 另外，他们提到Onrad在中国获得批准，但预计订单在第二半年，因为需要省级招标，这也不是限制，而是市场流程。 他们提到日本收入延迟，因为建设延迟，但这是外部因素，不是公司自身限制。 他们提到服务利润率下降，因为一次性费用，但这不是限制。 他们提到“我们预计2017财年将是一个增长年，但增长主要在下半年”，这暗示了上半年可能较弱，但并未明确说是因为公司无法交付。 关键点：管理层是否明确说“需求不是问题”？他们提到订单创纪录，但未说需求超过供应。他们提到“我们无法满足需求”了吗？没有。 在记录中，Josh Levine说：“我们相信2017财年将是一个增长年，尽管由于我们强调的原因，我们预计大部分增长将发生在下半年。”这暗示了上半年增长较弱，但原因可能是产品发布时机，而不是需求不足。 他们提到“我们正在安装和监控Radixact系统……我们将移动至全面商业发布”，这暗示了系统尚未完全准备好，但并未说需求被限制。 因此，我认为管理层没有明确地、自愿地详细说明公司自身的当前限制，同时明确需求不是问题。他们更多是在描述产品发布计划，而不是在承认无法满足现有需求。 所以答案应为NO。

← Back to the full ARAY analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management VOLUNTARILY AND SPECIFICALLY DETAIL THE COMPANY'S OWN CURRENT LIMITATIONS — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that DEMAND FOR WHAT IT SELLS IS NOT THE PROBLEM, and does management pair that candor with real remediation already underway? Answer YES when management's own account conveys, in whatever form fits the business, ONE coherent posture with all three present: (1) SPECIFIC SELF-IDENTIFIED LIMITS: management itself names concrete things the company currently cannot do or cannot do enough of — capacity it lacks, roles it cannot fill fast enough, systems or facilities not yet ready, output it cannot yet reach, orders it cannot yet serve — described plainly and unprompted rather than extracted defensively; (2) DEMAND TREATED AS PRESENT AND SETTLED: the business the company cannot fully serve is real and current (orders, customers, committed work, or arriving volume already in hand), so the limits are binding against actual business rather than hypothetical growth; and (3) FIXES IN MOTION: management describes the specific work already underway to remove each named limit — building, hiring, commissioning, qualifying — as executing now, not planned. The candor itself is the signal: management speaking like operators cataloguing bottlenecks rather than promoters selling a story. Answer NO if the limitations discussed are excuses for weak demand, competitive losses, or macro softness. NO if the constraints are shortages of purchased inputs with no unserved business of the company's own behind them. NO if management describes limits but no remediation already executing. NO if the discussion is generic ('we are capacity constrained', 'we are investing in growth') without named specific limits. NO if the company is comfortably serving everything asked of it. NO if the posture appears only in analyst questions management does not engage substantively. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
NOAH Noah Holdings Limited Q1 2024 2024-05-30 D
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
BRBR BellRing Brands, Inc. Q4 2023 2023-11-21 B+
GOLD Barrick Gold Corporation Q3 2023 2023-11-02 C
CMG Chipotle Mexican Grill, Inc. Q3 2023 2023-10-27 B+
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
TSSI TSS, Inc. Q4 2022 2023-04-03 D
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
PI Impinj, Inc. Q4 2022 2023-02-08 B+
CEIX CONSOL Energy Inc. Q4 2022 2023-02-07 B
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
FORM FormFactor, Inc. Q4 2021 2022-02-02 B
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
HNRG Hallador Energy Company Q3 2021 2021-11-09 C+
HY Hyster-Yale Materials Handling, Inc. Q3 2021 2021-11-06 D
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
FSS Federal Signal Corporation Q1 2018 2018-05-12 A
ACHC Acadia Healthcare Company, Inc. Q4 2017 2018-02-22 C+
AOSL Alpha and Omega Semiconductor Limited Q2 2018 2018-02-07 B
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
ZBH Zimmer Biomet Holdings, Inc. Q2 2017 2017-07-30 F
PLAB Photronics, Inc. Q2 2017 2017-05-17 C+
PPG PPG Industries, Inc. Q1 2017 2017-04-20 C

How the model reasoned

HY · Q3 2021 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...NO The transcript shows management identifying specific constraints around component shortages and supply chain issues that are limiting production and shipping, with record backlog indicating real demand. However, these limitations are framed as shortages of purchased inputs (components and logistics), which the question explicitly excludes from consideration. The remediation efforts mentioned (expanding teams to secure components) are underway, but the core issue is input constraints rather than the company's own production or operational limits. The candor is present, but it doesn't meet the full criteria for "company's own current limitations" as defined.
CEIX · Q4 2022 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...YES Management voluntarily details specific self-identified limits (staffing challenges preventing full staffing and optimization of CM super sections, supply chain and equipment delays, geological issues) unprompted. Demand is treated as present and settled through actual sales and marketing of coal, with the Itmann project ramp-up delayed despite committed production. Fixes are already in motion via recent changes, focus on staffing two sections, and transition to operations team oversight. This forms a coherent posture of candid bottleneck cataloguing paired with executing remediation.
ACHC · Q4 2017 → YESThe question is: Does management voluntarily and specifically detail the company's own current limitations — what it cannot yet produce, serve, staff, deliver, or handle — while making clear that dema...NO The transcript shows management addressing UK-specific constraints (nurse shortages, retrofitting beds, NHS transition delays) and noting real demand elements like census and community needs. However, it does not clearly convey a coherent posture where demand is explicitly treated as settled and unproblematic, with remediation already executing in a specific, 1-2-3 format. The discussion leans more toward operational challenges tied to external factors like NHS processes rather than purely internal limits paired with active fixes. Thus, it does not fully meet the criteria for a YES.

More from the question bank

Physical throughput records at the operatingThe economics improved before the volume arrSmall reported base, oversized already-contrNamed counterparty roster suddenly upgraded Repeat expansion inside the base while new lGeographic or market replication just starteAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.